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The Thyroid Gland Is a Major Source of Circulating T3 in the Rat
Jean-Pierre Chanoine, Lewis E. Braverman, Alan P. Farwell, Marjorie Safran, Sharon Alex,
Susan Dubord, and Jack L. Leonard
Departments ofNuclear Medicine, Physiology, and Medicine, University ofMassachusetts Medical Center,
Worcester, Massachusetts 01655
Abstract
In rats, the respective contribution of the thyroid and periph-
eral tissues to the pool ofT3 remains unclear. Most, ifnot all, of
the circulating T3 produced by extrathyroidal sources is gener-
ated by 5'-deiodination of T4, catalyzed by the selenoenzyme,
type I iodothyronine 5'-deiodinase (5'D-I). 5'D-I in the liver
and kidney is almost completely lost in selenium deficiency,
resulting in a marked decrease in T4 deiodination and an in-
crease in circulating T4 levels. Surprisingly, circulating T3 lev-
els are only marginally decreased by selenium deficiency. In
this study, we used selenium deficiency and thyroidectomy to
determine the relative contribution ofthyroidal and extrathyroi-
dal sources to the total body pool of T3. Despite maintaining
normal serum T4 concentrations in thyroidectomized rats by T4
replacement, serum T3 concentrations remained 55% lower
than those seen in intact rats. In intact rats, restricting selenium
intake had no effect on circulating T3 concentrations. Decreas-
ing 5D-1I activity in the liver and kidney by > 90% by restrict-
ing selenium intake resulted in a further 20% decrease in serum
T3 concentrations in the thyroidectomized, T4 replaced rats,
suggesting that peripheral T4 to T3 conversion in these tissues
generates approximately 20% of the circulating T3 concentra-
tions. While dietary selenium restriction markedly decreased
intrahepatic selenium content (> 95%), intrathyroidal sele-
nium content decreased by only 27%. Further, thyroid 5D-1I
activity actually increased 25% in the selenium deficient rats,
suggesting the continued synthesis of this selenoenzyme over
selenoproteins in other tissues in selenium deficiency. These
data demonstrate that the thyroid is the major source of T3 in
the rat and suggest that intrathyroidal T4 to T3 conversion may
account for most of the T3 released by the thyroid. (J. Clin.
Invest. 1993. 91:2709-2713.) Key words: deiodination * sele-
nium - thyroid * hormone metabolism * T4 to T3 conversion
Introduction
In mammals, the relative contribution of thyroidal and ex-
trathyroidal sources to the total body pool ofthe metabolically
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active iodothyronine, 3,5,3'-triiodothyronine (T3), is unclear.
T3 can be derived from conversion ofthe prohormone thyrox-
ine (T4) by outer ring (5'-) deiodination in the peripheral tis-
sues, by T4 to T3 conversion within the thyroid gland, and by
direct secretion ofde novo synthesized thyroidal T3. Estimates
ofthe contribution ofextrathyroidal T4 to T3 conversion to the
total T3 pool vary from 20% to 100% in the rat ( 1-3) and the
thyroid accounts for the remainder of the T3 produced daily.
Laurberg used in situ thyroid perfusion to directly examine the
contribution of the thyroid to the T3 pool and reported that
intrathyroidal T4 to T3 conversion accounted for a consider-
able portion of the T3 secreted from the dog thyroid (4, 5).
Thus, both extrathyroidal and intrathyroidal T4 to T3 conver-
sion appear to participate in the daily production of T3.
T4 to T3 conversion is catalyzed by the enzyme, iodothyro-
nine 5'-deiodinase. Two isozymes ofiodothyronine 5'-deiodin-
ase have been identified. The most abundant form, type I io-
dothyronine 5'-deiodinase (5D-I), is found in liver, kidney,
and thyroid (6) and contains the rare amino acid selenocys-
teine (7-9). Tissue content of 5 D-I in the liver and kidney is
proportional to selenium intake (10). The other isozyme, type
II iodothyronine 5'deiodinase (5D-IT), is abundant in the
brain, pituitary, and brown adipose tissue and does not contain
selenium (11, 12). T3 generated by 5 DI is released into the
general circulation, while the majority of the T3 produced by
5D-1I remains with the cell. The ability to manipulate 5'D-I
levels by altering the dietary intake of selenium provides the
means to examine the contribution of S'D-I to total T3 produc-
tion. Selenium deficiency leads to an almost complete loss of
5D-I in the liver and kidney and a 40-50% increase in the
serum T4 concentration ( 10, 12-14). This increment in circu-
lating T4 is completely accounted for by the prolonged meta-
bolic half-life ofthe iodothyronine due to the loss of5'D-I ( 14).
Paradoxically, serum T3 concentrations are not reciprocally
affected and decrease by no more than 20%, if at all ( 12-14).
While serum T3 concentrations are marginally depressed by
selenium deficiency, circulating T3 sulfate concentrations in-
crease nearly twofold ( 12, 14). Serum TSH levels remain near
normal despite the elevated circulating T4 in the selenium-defi-
cient animal ( 12-14). Thus, despite the marked decrease in
hepatic and renal T4 to T3 conversion in the absence of sele-
nium, other sources of T3 appear to be made available in ani-
mals lacking 5D-I.
There are several possibilities to account for the discor-
dance between the near complete loss of 5D-I and the mar-
ginal fall in circulating T3 observed in selenium deficiency.
They include (a) diminished T3 clearance, (b) increased thy-
roidal 13 secretion, and/or (c) enhanced recovery of T3 from
sulfo-conjugates released into the gut in the enterohepatic cy-
cle. Previous work has shown that T3 clearance is only margin-
ally decreased by selenium deficiency and that the 20-25% in-
crease in the metabolic half-life of this iodothyronine is insuffi-
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cient to maintain the steady-state levels of T3 observed in
serum ( 14). The contribution of the thyroid to the T3 pool in
the selenium-deficient rat remains to be determined. Likewise,
the contribution of enterohepatic recycling of T3 or its conju-
gates to the circulating T3 pool is unclear.
In this study, we determined the source(s) ofcirculating T3
in selenium-deficient rats. The data show that the thyroid gland
serves as a major source of circulating T3 in the rat and suggest
that intrathyroidal T4 to T3 conversion accounts for much of
the T3 secreted by the thyroid.
Methods
Animals and reagents. Weanling male Sprague-Dawley rats (40-50 g)
supplied by Charles River Laboratories (Wilmington, MA) were used
in all experiments. The study was approved by the Animal Research
Committee and complies with the institutional assurance certificate of
the University of Massachusetts Medical Center. Rats were fed a torula
yeast based semisynthetic diet (Teklad Premier Laboratory Diets, Mad-
ison, WI) for 5 wk. The selenium-deficient diet (TD 86298) contains
less than 16 ,gg/kg selenium and the selenium-replete diet (ID 91259)
is the same base diet supplemented with 200 ug/kg selenium as
Na2SeO3. Rats were housed in stainless steel cages, and distilled water
was available ad lib. Body weight (BW)' was monitored biweekly.
Analyticalprocedures and hormone assays. In all experiments, ani-
mals were killed by decapitation and exsanguinated, except where
noted. Liver was homogenized in 4 vol (wt/vol) of 20 mM potassium
phosphate buffer (pH 7.4), 150mM NaCl, and in 4 vol (wt/vol) of250
mM sucrose, 20 mM Hepes buffer (pH 7.0), 1 mM EDTA, and 1 mM
DTT and stored at -20°C for determination ofglutathione peroxidase
activity (GPx) and 5D-I activity, respectively. Thyroid glands were
weighed and homogenized in 800 Ml of250mM sucrose, 20mM Hepes
buffer (pH 7.0), 1 mM EDTA, and 1 mM DTT for determination of
5'D-I activity.
The degree ofselenium deficiency in the rats was determined by the
decrease in hepatic GPx activity. GPx activity was determined from the
oxidation ofNADPH in the presence of 0.35 mM t-butyl hydroperox-
ide monitored spectrophotometrically at 340 nm ( 15). Samples were
run in duplicate and results were expressed as nmol NADPH oxidized/
min per mg protein. Hepatic GPx activities in intact, selenium-replete
and thyroidectomized, T4 replaced, selenium-replete rats were 598±58
nmol NADPH oxidized/ min per mg protein (n = 9) and 906±53 nmol
NADPH oxidized/min per mg protein (n = 12), respectively.
Type I iodothyronine 5'-deiodinase activity was determined by the
release of radioiodide from 10 MM [ '25I] rT3 in the presence of 20 mM
DTT (5'D-I) (16). Samples were run in duplicate and results were
expressed as units/mg protein; 1 unit of 5'D-I enzyme activity repre-
sents the release of 1 pmol radioiodine/min per mg protein at 37°C.
Hepatic type I iodothyronine 5'-deiodinase activities in intact, sele-
nium-replete and thyroidectomized, T4 replaced, selenium-replete rats
were 224±15 U/mg protein (n = 12) and 114±8 U/mg protein (n
= 9), respectively.
Serum TSH was measured in duplicate by RIA using materials
obtained from the National Pituitary Agency, National Institutes of
Health (Bethesda, MD). Serum T4 and T3 concentrations were deter-
mined in duplicate by species-adapted specific RIAs.
Selenium was quantified by measuring the 162 KeV gamma ray
produced during the decay of radioactive "mSe after irradiation ofthe
sample at a neutron flux. The sensitivity was 0.05 ppm (Research Reac-
tor Facility, University of Missouri-Columbia, Columbia, MO) ( 17).
Protein was measured by the method of Bradford ( 18).
1. Abbreviations used in this paper: BW, body weight; GPx, glutathione
peroxidase activity.
Experimental procedures
Effect ofaltered selenium intake on serum T4, T3, and TSH concentra-
tions in T4 replaced, thyroidectomized rats. 35 rats (22 selenium sup-
plemented and 13 selenium deficient) were used in this experiment. 3
wk before being killed, 12 selenium-supplemented and 6 selenium-de-
ficient rats were anesthetized using 7 mg ketamine and 0.6 mg xyla-
zine/ 100 g BW and the thyroid glands removed. T4 replacement was
begun one day after thyroidectomy by daily intraperitoneal injections
of T4 ( 1.1 g/ 100 g BW) for 2 wk. For the final 7 d of the experiment,
serum T4 concentrations were maintained at euthyroid levels by the
use of an osmotic minipump (Alzet 2001; Alza Corp., Palo Alto, CA)
calculated to deliver T4 at a rate of 1.1 ug/ 100 gBW per day. T4 (Sigma
Chemical Co., St. Louis, MO) used for hormone replacement was
> 99.7% pure as measured by HPLC.
Effect of selenium deficiency on the selenium content and 5D-I
activity in the thyroid gland. 15 rats (8 selenium supplemented, and 7
selenium deficient) were anesthetized as described above and perfused
through the aorta with 40 ml of ice-cold saline. The exsanguinated
thyroid gland and liver were removed and frozen at -70'C for subse-
quent determination of selenium content by neutron activation analy-
sis. In a parallel experiment, thyroidal and liver 5'D-I activities were
determined in 10 selenium-supplemented and 10 selenium-deficient
rats.
Effects of selenium deficiency on intrathyroidal metabolism of 13 1.
Intrathyroidal metabolism of 13'I was determined in groups of 5 rats (5
selenium supplemented and 5 selenium deficient). Animals were killed
2 h after the intraperitoneal injection of 10 MC Na 31I ( 16.2 Ci/,Mg).
Thyroid glands were then dissected free of connective tissue and ho-
mogenized in 500 ,l of sodium barbital buffer (pH 8.6) containing 20
mM methimazole and 4 mM KI. The percent uptake of radioiodide
and the distribution of the 1311 between MIT, DIT, T3, and T4 was
determined by descending paper chromatography after pronase diges-
tion of thyroidal homogenates according to Vagenakis et al. ( 19).
Statistics
The results are presented as mean±SE. Statistical significance (P
< 0.05) was determined using the Student's t test for unpaired values.
Results
Effects ofselenium status on serum T4, T3, and TSH concen-
trations in T4 replaced, thyroidectomized rats. During the 5-wk
experimental period, body weights increased from 55 to 330 g
in the euthyroid rats (intact) (n = 17) and from 55 to 289 g in
the thyroidectomized rats replaced with T4 (14 replaced) (n
= 18), indicating that hormone replacement was almost com-
plete in the thyroidectomized animals. No differences in
growth were observed between the selenium-deficient and sele-
nium-supplemented rats. Selenium deficiency resulted in a
97% decrease in hepatic GPx activity and a parallel 93% de-
crease in hepatic 5'D-I activity in both the intact and T4-re-
placed rats indicating that the animals were selenium deficient.
As shown in Fig. 1, in selenium-supplemented rats, serum T4
concentrations were similar in the intact and T4 replaced
groups (A). Selenium deficiency resulted in the expected in-
crease in the serum T4 concentrations in both the intact and T4
replaced groups (P < 0.05, A vs. B).
Although the serum T4 concentrations were identical in the
selenium-supplemented intact and T4 replaced rats, serum T3
concentrations were not normalized and T3 concentrations in
the T4 replaced rats remained 55% lower than those in the
intact group (Fig. 1 C). Selenium deficiency did not signifi-
cantly affect serum T3 values in the intact rats ( 1.23 nM±O. 14
vs. 1.1 1±0.10, selenium-supplemented vs. selenium-deficient
2710 Chanoine, Braverman, Farwell, Safran, Alex, Dubord, and Leonard
Se+
100
g 75
s
E 50
20
co
25
0
200
E 1.5
~-
E 1.0
0
o
0.5
0.0
400
D 300
E
i- 200.
E
An 100
0
100
75
E 50
(%25
IJLA 0
100
SE
:E 15-5
* EI 1.0.
0
CO~~~~~o
0.5
.400-
* , 300
E
coI-- 200
E
100
01
F
I
E °6c
oX,0w
E*._
Ea
CO
* Intact. 0 T4 Replaced
Figure 1. Effect of selenium and thyroidectomy on serum concentra-
tions of T4, T3, and TSH in the rat. Rats were fed a defined diet,
thyroidectomized, and replaced with T4 as described in Experimental
procedures. Blood was obtained at the time of killing and analyzed
for T4, T3, and TSH. Intact, nonthyroidectomized rats; T4 replaced,
rats thyroidectomized and replaced with exogenous T4. *P < 0.05.
rats, respectively) but decreased the serum T3 concentrations
by 20% in the T4 replaced group (C and D) (0.55±0.03 nM vs.
0.44±0.02 nM, P < 0.05 selenium-supplemented vs. selenium-
deficient rats, respectively).
In both selenium-supplemented and selenium-deficient thy-
roidectomized rats, T4 replacement did not normalize the
serum TSH concentrations, and they remained 2 to 3 times
higher than those observed in the intact rats (Fig. 1, E and F).
Selenium deficiency did not affect serum TSH concentrations
in the intact rats.
Effect ofselenium deficiency on selenium content and S'D-I
activity in the thyroid. The failure ofT4 replacement to normal-
ize serum T3 concentrations in the selenium-supplemented
rats, despite the availability of normal T4 levels to the 5D-I
containing tissues, suggested that the thyroid gland may con-
tribute up to 55% ofthe T3 found in the circulation. Similarly,
the thyroid appeared to contribute as much as 60% ofthe circu-
lating T3 in the selenium-deficient rats, animals that lack the
selenoprotein 5SD-I in the liver and kidney. Since earlier work
suggested that intrathyroidal T4 to T3 conversion was a major
contributor to the T3 found in the dog thyroid effluent (4, 5),
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Figure 2. Effect of selenium deficiency on the selenium content in the
thyroid and liver. Rats were fed a selenium-supplemented (Se+) or
selenium-deficient (Se-) diet for 5 wk then were killed. Selenium
content was determined as described in Experimental procedures. *P
< 0.05.
and thyroidal 59D-I appears to be a selenoprotein (7), the near
normal serum T3 concentrations found in intact, selenium-de-
ficient animals raised the possibility that thyroidal 5D-I was
unaffected by selenium deficiency. Thus, we determined the
effects of selenium deficiency on thyroidal selenium content
(Fig. 2) and on 5 D-I activity in the thyroid (Fig. 3). Rats fed
the selenium-deficient diet had a > 97% fall in selenium con-
tent in the liver and a corresponding > 93% decrease in liver
5D-I activity. However, in the thyroid, the selenium-deficient
diet resulted in only a modest 27% decrease in selenium con-
tent, and paradoxically, the 5D-I activity was increased by 25%
(P < 0.05).
Effects ofselenium deficiency on intrathyroidal metabolism
of"' I. To evaluate the influence ofaltered selenium intake on
intrathyroidal iodine metabolism, we determined the effects of
selenium deficiency on the thyroid gland's ability to concen-
trate and organify iodine. Thyroidal uptake of "'lI was unaf-
fected by selenium intake, and there were no differences in the
synthesis of the 13'1-labeled iodotyrosines (MIT and DIT) or
iodothyronines (T4 and T3) between selenium-deficient and
selenium-supplemented rats (Table I).
Discussion
Controversy surrounds the contribution of the various tissues
to T3 production in the rat. DiStefano (1) estimated that 47%
ofT3 originates from both thyroidal secretion and extrathyroi-
dal T4 to T3 conversion in liver and kidney, while the remain-
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Figure 3. Effect of selenium deficiency on SD-I activity in the thyroid
and liver. Rats were fed a selenium-supplemented (Se+) or sele-
nium-deficient (Se-) diet for 5 wk then were killed. 5D-I activity
was assayed as described in Experimental procedures. *P < 0.05.
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Table I. Effect ofSelenium on Intrathyroidal 13"I Metabolism
Se+ Se-
% Uptake 9.4±1.3 12.7±3.2
% MIT 27.4±0.6 27.0±2.2
% DIT 41.4±1.6 36.9±1.5
MIT/DIT 0.74±0.08 0.67±0.03
% T3 1.0±0.3 1.1±0.2
% T4 4.1±0.5 3.1±0.3
T3/T4 0.33±0.06 0.25±0.06
Intrathyroidal metabolism of '1'I was determined in 5 selenium-sup-
plemented (Se+) and 5 selenium-deficient (Se-) rats as described in
Experimental procedures. Results are expressed as mean±SE.
ing 53% comes from T4 to T3 conversion in the slowly equili-
brating pools, such as brain, skin, and muscle. Kinlaw et al. (3)
revised their earlier estimate that only 20% ofT3is produced by
extrathyroidal T4 to T3 conversion in the rat (2) and suggested
that essentially all T3 is produced by T4 to T3 conversion. They
also speculated that there is little or no direct secretion ofT3 by
the thyroid.
The current data demonstrate that at least 55% of circulat-
ing T3 comes from the thyroid gland in the intact, selenium-
supplemented rat. Since liver and kidney 5 D-I still contribute
to the pool of circulating T3 in these rats, it is difficult to esti-
mate the relative contribution of the thyroid to total body T3
concentrations. Moreover, the failure ofT4 replacement to nor-
malize serum T3 concentrations in thyroidectomized rats, re-
sulting in reduced liver 5'D-I activity, further complicates the
analysis of the sources of circulating T3. However, in the sele-
nium-deficient rat, liver and kidney 5'D-I are virtually absent
( 12), and the contribution of the thyroid to the serum T3 pool
can be approximated. The contribution ofthyroidal T3 derived
from thyroglobulin and that from thyroidal T4 to T3 conver-
sion to the circulating T3 pool in these animals, as estimated
from the data presented in Fig. 1 panel D, is approximately
65% and the residual serum T3 concentrations present in these
rats lacking both the thyroid and extrathyroid 5'D-I is in excel-
lent agreement with previously measured values ( 12). The
source ofthe residual T3 in the serum ofthyroidectomized rats
with essentially undetectable serum T4 concentrations and no
hepatic and renal 5'D-I remains unclear. Taken together, ex-
trathyroidal T4 to T3 conversion contributes 20-25%, and thy-
roidal T4 to T3 conversion and T3 derived from thyroglobulin
contributes 55-65% of the total body pool of T3. Thus, nearly
all the circulating T3 derived from T4 appears to be produced
by the selenoenzyme, 5'D-I.
Thyroidectomy resulted in a marked increase in serum
TSH concentrations in both selenium-supplemented and sele-
nium-deficient rats despite the maintenance of serum T4 con-
centrations identical to those observed in the respective intact
groups. The presence of increased serum TSH concentrations,
decreased serum T3 concentrations, and normal or elevated
serum T4 concentrations indicates that circulating T3 plays an
important role in regulating TSH secretion ( 12, 20, 21 ). Previ-
ously, we found a modest increase in serum TSH concentra-
tions ( 12) in selenium-deficient rats that was proportional to
the fall in circulating T3 suggesting that TSH levels may actu-
ally be slightly elevated for some period during dietary restric-
tion of selenium.
Dietary restriction of selenium intake had only a marginal
effect on the selenium content and levels of the selenoenzyme
5'D-I in the thyroid gland. Thus, while there was a near com-
plete loss in hepatic selenium content and 5DI activity, the
thyroid preserves its selenium stores and 5D-I activity was in-
creased by 25% in selenium-deficient rats. This increase in thy-
roidal 5D-I may be due to TSH mediated stimulation of 5'D-I
activity (22, 23) resulting from small increases in circulating
TSH that may occur in selenium-deficient rats. Thus, despite
the loss of extrathyroidal T4 to T3 conversion, the thyroid re-
tains the ability to catalyze the 5'deiodination of T4.
Similar preservation of thyroidal selenium stores was re-
cently observed in rats fed a selenium-deficient diet for two
generations. Behne and co-workers have observed that the thy-
roid gland and brain exhibited the highest avidity for selenium
(24). Arthur et al. (25) recently found that thyroidal GPx activ-
ity fell by 50% after 5 wk of selenium deficiency. Since the
25% increase in thyroidal 5D-I occurred during this same time
period in our studies, these data suggest that the thyroid is
resistant to the effects ofselenium deficiency and that thyroidal
5'D-I is preserved over other selenoproteins in selenium-defi-
cient animals. The thyroid is not unique in this regard since the
testis and brain also preferentially preserve selenium over other
organs (26).
In this study, intrathyroidal iodine metabolism was also
unaffected by selenium deficiency, whereas inconsistent results
have been reported on the effects of selenium deficiency on
intrathyroidal metabolism by others. Goldstein et al. observed
a decrease in PB 13"I after in vitro incubation of thyroid glands
from selenium-deficient rats with 131I (27). Arthur et al. (25)
found a decrease in both T4 and T3 content in the thyroid gland
from selenium-deficient rats, while Meinhold et al. (28) found
no change in T4 and T3 content in the thyroid from rats fed a
selenium-deficient diet. Taken together, these data suggest that
secretion of de novo synthesized T3 is unaffected by selenium
deficiency. It is generally assumed that 70-80% ofthe circulat-
ing T3 concentrations (29, 30) is derived from T4 to T3 conver-
sion in human and similar, albeit, more variable estimates have
been made for the rat and that the liver, kidney, and thyroid
contain nearly all the 5D-I activity in the body (6, 30). Since
extrathyroidal 5'D-I contributes 10-25% ofthe T3 production
(see above), then more than 50% of the T3 in the thyroidal
effluent is likely to be derived from intrathyroidal T4 to T3
conversion of T4 liberated from thyroglobulin.
The finding that the majority of T3 in the rat derives from
the thyroid provides a potential explanation for the apparent
discordance between the observed Km of 5 D-I and the concen-
tration of T4 available to extrathyroidal tissues. In vitro esti-
mates ofthe Km forT4 for 5D-I range between 0.5 and 1 IM (6,
30), while the T4 available to the tissues ("free hormone") is
3-4 orders of magnitude less, indicating that catalysis by 5'D-I
in peripheral tissues is very inefficient. However, intracellular
T4 levels in the thyroid would be expected to be much greater
than those in the circulation, and the Km for T4 of 5D-I may
reflect the substrate available in the thyroid rather than that in
the circulation.
In conclusion, the current study demonstrates that the thy-
roid gland is a major source of circulating T3 in rats, account-
ing for approximately 55% of total T3 production. The contri-
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bution ofintrathyroidal T4 to T3 conversion to T3 homeostasis
appears to be important, but the exact contribution remains to
be determined.
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